{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The P re- O perative W indow of E ndocrine Therapy to Inform R adiation Therapy Decisions (POWER, NCT04272801 ) Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "37 POWER Trial participants who completed pre-ET and surgery"
      },
      "Participants": {
        "score": 2,
        "evidence": "older women with early-stage, ER-positive breast cancer"
      },
      "Intervention": {
        "score": 2,
        "evidence": "3 months of pre-operative endocrine therapy (pre-ET)"
      },
      "Objective": {
        "score": 1,
        "evidence": "aims to determine whether 3 months of pre-operative endocrine therapy (pre-ET) informs adjuvant radiation therapy decisions"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "Ki-67 decreased from 13% in biopsy specimens to 5% in the lumpectomy specimens"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "37 POWER Trial participants"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "37 POWER Trial participants who completed pre-ET and surgery"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Ki-67 decreased from 13% in biopsy specimens to 5% in the lumpectomy specimens (p<0.001)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT04272801"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}